Scarica l'app Stockscreener
0.8404
3.26%
-0.0283
Dopo l'orario di chiusura:
.85
0.0096
+1.14%
Precedente Chiudi:
$0.8687
Aprire:
$0.8906
Volume 24 ore:
46,682
Relative Volume:
0.14
Capitalizzazione di mercato:
$4.38M
Reddito:
-
Utile/perdita netta:
$-18.68M
Rapporto P/E:
-0.1136
EPS:
-7.3948
Flusso di cassa netto:
$-15.70M
1 W Prestazione:
-11.32%
1M Prestazione:
-18.41%
6M Prestazione:
-87.78%
1 anno Prestazione:
-93.05%
Intervallo 1D:
$0.836
$0.8906
Intervallo di 1 settimana:
$0.836
$0.9782
Portata 52W:
$0.731
$14.68
Fibrobiologics Inc Stock (FBLG) Company Profile
Nome
Fibrobiologics Inc
Settore
Industria
Telefono
281-671-5150
Indirizzo
455 E. MEDICAL CENTER BLVD, HOUSTON
Compare FBLG vs VRTX, REGN, ARGX, ALNY, RVMD
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
FBLG
Fibrobiologics Inc
|
0.8404 | 4.52M | 0 | -18.68M | -15.70M | -7.3948 |
VRTX
Vertex Pharmaceuticals Inc
|
522.25 | 134.41B | 12.34B | 4.34B | 3.71B | 16.87 |
REGN
Regeneron Pharmaceuticals Inc
|
676.23 | 68.13B | 14.92B | 4.42B | 3.79B | 41.04 |
ARGX
Argen X Se Adr
|
919.94 | 57.01B | 4.16B | 1.29B | 734.26M | 19.58 |
ALNY
Alnylam Pharmaceuticals Inc
|
321.59 | 41.79B | 4.29B | 577.22M | 641.34M | 4.2086 |
RVMD
Revolution Medicines Inc
|
190.46 | 40.39B | 742.00K | -1.37B | -1.07B | -7.0731 |
Fibrobiologics Inc Stock (FBLG) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2024-12-12 | Iniziato | Rodman & Renshaw | Buy |
| 2024-10-30 | Iniziato | H.C. Wainwright | Buy |
| 2024-09-24 | Iniziato | Maxim Group | Buy |
Fibrobiologics Inc Borsa (FBLG) Ultime notizie
FibroBiologics completes third batch of diabetic foot ulcer drug - Investing.com
FibroBiologics says one more batch should finish its diabetes foot ulcer trial - Stock Titan
FibroBiologics to Participate in Fireside Chat at H.C. Wainwright 4th Annual Cell Therapy Virtual Conference - BioSpace
FibroBiologics CEO, chief scientist join cell therapy conference chat - Stock Titan
FibroBiologics Secures Up to $9 Million in At-the-Market Private Placement to Advance Cell Therapy Pipeline 1 - Minichart
FibroBiologics closes $3M private placement with warrants - Investing.com UK
FibroBiologics closes $3M private placement with warrants By Investing.com - Investing.com South Africa
FibroBiologics Raises $3.0 Million in Private Placement; Issues Pre-Funded and Common Warrants - TradingView
FibroBiologics (FBLG) closes $3M placement with $6M warrant upside - Stock Titan
FibroBiologics Announces Closing of up to $9.0 Million Private Placement Priced At-the-Market Under Nasdaq Rules - STLtoday.com
FibroBiologics, Inc. announced that it has received $3 million in funding - marketscreener.com
Press Release: FibroBiologics Announces up to $9.0 Million Private Placement Priced At-the-Market Under Nasdaq Rules - 富途牛牛
Enterprise value to revenue forward of FibroBiologics, Inc. – NASDAQ:FBLG - TradingView
Price to book forward of FibroBiologics, Inc. – NASDAQ:FBLG - TradingView
Price to earnings forward of FibroBiologics, Inc. – NASDAQ:FBLG - TradingView
Enterprise value to EBIT forward of FibroBiologics, Inc. – FWB:SG00 - TradingView
Enterprise value to revenue forward of FibroBiologics, Inc. – FWB:SG00 - TradingView
Number of shareholders of FibroBiologics, Inc. – NASDAQ:FBLG - TradingView
Enterprise value to EBITDA forward of FibroBiologics, Inc. – FWB:SG00 - TradingView
Price to sales forward of FibroBiologics, Inc. – FWB:SG00 - TradingView
FibroBiologics, Inc. Actuals & Estimates (NASDAQ:FBLG) - TradingView
FibroBiologics raises $3M in private placement offering By Investing.com - Investing.com Australia
FibroBiologics (FBLG) Prices $9M Private Placement with Warrants - GuruFocus
FibroBiologics, Inc. Actuals & Estimates (LS:A426UV) - TradingView
FibroBiologics (FBLG) Secures $3M Through Private Placement Offe - GuruFocus
FibroBiologics raises $3M in private placement offering - Investing.com
FibroBiologics Announces up to $9.0 Million Private Placement Priced At-the-Market Under Nasdaq Rules - STLtoday.com
FBLG Forecast — Price Target — Prediction for 2027 - TradingView
SG00 Forecast — Price Target — Prediction for 2027 - TradingView
A426UV Forecast — Price Target — Prediction for 2027 - TradingView
FibroBiologics, Inc. announced that it expects to receive $3 million in funding - marketscreener.com
Form 8K Fibrobiologics Inc For: 23 June By Investing.com - Investing.com India
FibroBiologics, Inc. Adopts 2026 Equity and Incentive Compensation Plan – Key Terms, Stock Option Agreement & SEC Filing Overview – Minichart - Minichart
Form 4 Fibrobiologics Inc For: 23 June By Investing.com - Investing.com Nigeria
Form 8K Fibrobiologics Inc For: 23 June - Investing.com UK
Director at FibroBiologics (FBLG) receives stock options for 30,803 shares - Stock Titan
FibroBiologics (FBLG) director receives grant of 30,803 stock options at $0.7503 - Stock Titan
30,803 options granted to FibroBiologics (FBLG) director Olivia - Stock Titan
FibroBiologics stockholders approve new equity and incentive compensation plan By Investing.com - Investing.com Nigeria
FibroBiologics stockholders approve new equity and incentive compensation plan - Investing.com
[8-K] FibroBiologics, Inc. Reports Material Event - Stock Titan
Fibrobiologics, Inc. Announces Non Standing for Re-Election of Stacy Coen to the Board - marketscreener.com
FibroBiologics (FBLG) AGM 2026 Summary - Quartr
FibroBiologics | 4: Statement of changes in beneficial ownership of securities-Director Niklas Victoria Ninon Olivia - Moomoo
FBLG: All proposals passed, board changes noted, and Nasdaq compliance risks discussed - TradingView
FibroBiologics receives patent allowance for wound therapy - Investing.com UK
FibroBiologics receives patent allowance for wound therapy By Investing.com - Investing.com Nigeria
Fibrobiologics Inc Azioni (FBLG) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Fibrobiologics Inc Azioni (FBLG) insider trading
| Commercio interno | Relazione | Data | Transazione | Costo | #Azioni | Valore ($) | #Azioni Totale |
|---|---|---|---|---|---|---|---|
| O'HEERON PETE | CHIEF EXECUTIVE OFFICER |
Mar 03 '26 |
Buy |
0.41 |
18,200 |
7,373 |
5,942,275 |
| O'HEERON PETE | CHIEF EXECUTIVE OFFICER |
Mar 02 '26 |
Buy |
0.35 |
17,428 |
6,152 |
5,924,075 |
| O'HEERON PETE | CHIEF EXECUTIVE OFFICER |
Mar 04 '26 |
Buy |
0.38 |
15,872 |
6,006 |
5,958,147 |
| Davis Jason | Chief Financial Officer |
Mar 02 '26 |
Buy |
0.41 |
70,000 |
28,973 |
70,000 |
| GARCIA RUBEN A | General Counsel |
Feb 27 '26 |
Buy |
0.33 |
40,000 |
13,056 |
180,000 |
| GARCIA RUBEN A | General Counsel |
Dec 11 '25 |
Buy |
0.34 |
140,000 |
47,600 |
140,000 |
1.17%
2.48%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):